SEC Comment Letter 0000000000-24-007169 to Phathom Pharmaceuticals, Inc. (PHAT) (CIK 0001783183) (PHAT)
Phathom Pharmaceuticals, Inc. (PHAT) (CIK 0001783183)
Date: June 25, 2024 · CIK: 0001783183 · Accession: 0000000000-24-007169
AI Filing Summary & Sentiment
File numbers found in text: 001-39094
Letter
United States securities and exchange commission logo June 25, 2024 Molly Henderson Chief Financial Officer Phathom Pharmaceuticals, Inc. 100 Campus Drive, Suite 102 Florham Park, New Jersey 07932 Re:Phathom Pharmaceuticals, Inc. Form 10-K for Fiscal Year Ended December 31, 2023 File No. 001-39094 Dear Molly Henderson: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
United States securities and exchange commission logo
June 25, 2024
Molly Henderson
Chief Financial Officer
Phathom Pharmaceuticals, Inc.
100 Campus Drive, Suite 102
Florham Park, New Jersey 07932
Re:Phathom Pharmaceuticals, Inc.
Form 10-K for Fiscal Year Ended December 31, 2023
File No. 001-39094
Dear Molly Henderson:
We have completed our review of your filings. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences